Literature DB >> 23690546

The iodide-transport-defect-causing mutation R124H: a δ-amino group at position 124 is critical for maturation and trafficking of the Na+/I- symporter.

Viktoriya Paroder1, Juan P Nicola, Christopher S Ginter, Nancy Carrasco.   

Abstract

Na(+)/I(-) symporter (NIS)-mediated active accumulation of I(-) in thyrocytes is a key step in the biosynthesis of the iodine-containing thyroid hormones T3 and T4. Several NIS mutants have been identified as a cause of congenital I(-) transport defect (ITD), and their investigation has yielded valuable mechanistic information on NIS. Here we report novel findings derived from the thorough characterization of the ITD-causing mutation R124H, located in the second intracellular loop (IL-2). R124H NIS is incompletely glycosylated and colocalizes with endoplasmic reticulum (ER)-resident protein markers. As a result, R124H NIS is not targeted to the plasma membrane and therefore does not mediate any I(-) transport in transfected COS-7 cells. Strikingly, however, the mutant is intrinsically active, as revealed by its ability to mediate I(-) transport in membrane vesicles. Of all the amino acid substitutions we carried out at position 124 (K, D, E, A, W, N and Q), only Gln restored targeting of NIS to the plasma membrane and NIS activity, suggesting a key structural role for the δ-amino group of R124 in the transporter's maturation and cell surface targeting. Using our NIS homology model based on the structure of the Vibrio parahaemolyticus Na(+)/galactose symporter, we propose an interaction between the δ-amino group of either R or Q124 and the thiol group of C440, located in IL-6. We conclude that the interaction between IL-2 and IL-6 is critical for the local folding required for NIS maturation and plasma membrane trafficking.

Entities:  

Keywords:  Congenital iodide transport defect; Impaired intracellular trafficking; Membrane vesicles; Na+/I- symporter (NIS); Plasma membrane targeting

Mesh:

Substances:

Year:  2013        PMID: 23690546      PMCID: PMC3730242          DOI: 10.1242/jcs.120246

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  54 in total

1.  Na(+)/I(-) symporter activity requires a small and uncharged amino acid residue at position 395.

Authors:  Orsolya Dohán; M Verónica Gavrielides; Christopher Ginter; L Mario Amzel; Nancy Carrasco
Journal:  Mol Endocrinol       Date:  2002-08

2.  Molecular analysis of a congenital iodide transport defect: G543E impairs maturation and trafficking of the Na+/I- symporter.

Authors:  Antonio De la Vieja; Christopher S Ginter; Nancy Carrasco
Journal:  Mol Endocrinol       Date:  2005-06-23

3.  Immunohistochemical profile of the sodium/iodide symporter in thyroid, breast, and other carcinomas using high density tissue microarrays and conventional sections.

Authors:  Irene L Wapnir; Matt van de Rijn; Kent Nowels; Peter S Amenta; Kelly Walton; Kelli Montgomery; Ralph S Greco; Orsolya Dohán; Nancy Carrasco
Journal:  J Clin Endocrinol Metab       Date:  2003-04       Impact factor: 5.958

4.  Partial restoration of defective chloride conductance in DeltaF508 CF mice by trimethylamine oxide.

Authors:  H Fischer; N Fukuda; P Barbry; B Illek; C Sartori; M A Matthay
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2001-07       Impact factor: 5.464

5.  Failure of membrane targeting causes the functional defect of two mutant sodium iodide symporters.

Authors:  J Pohlenz; L Duprez; R E Weiss; G Vassart; S Refetoff; S Costagliola
Journal:  J Clin Endocrinol Metab       Date:  2000-07       Impact factor: 5.958

6.  Post-transcriptional regulation of the sodium/iodide symporter by thyrotropin.

Authors:  C Riedel; O Levy; N Carrasco
Journal:  J Biol Chem       Date:  2001-04-04       Impact factor: 5.157

7.  Autosomal recessive renal glucosuria attributable to a mutation in the sodium glucose cotransporter (SGLT2).

Authors:  L P van den Heuvel; K Assink; M Willemsen; L Monnens
Journal:  Hum Genet       Date:  2002-09-27       Impact factor: 4.132

8.  Identification and pharmacological correction of a membrane trafficking defect associated with a mutation in the sulfonylurea receptor causing familial hyperinsulinism.

Authors:  C J Partridge; D J Beech; A Sivaprasadarao
Journal:  J Biol Chem       Date:  2001-07-16       Impact factor: 5.157

9.  The Q267E mutation in the sodium/iodide symporter (NIS) causes congenital iodide transport defect (ITD) by decreasing the NIS turnover number.

Authors:  Antonio De La Vieja; Christopher S Ginter; Nancy Carrasco
Journal:  J Cell Sci       Date:  2004-01-20       Impact factor: 5.285

Review 10.  Molecular basis for glucose-galactose malabsorption.

Authors:  Ernest M Wright; Eric Turk; Martin G Martin
Journal:  Cell Biochem Biophys       Date:  2002       Impact factor: 2.194

View more
  13 in total

Review 1.  The Sodium/Iodide Symporter (NIS): Molecular Physiology and Preclinical and Clinical Applications.

Authors:  Silvia Ravera; Andrea Reyna-Neyra; Giuseppe Ferrandino; L Mario Amzel; Nancy Carrasco
Journal:  Annu Rev Physiol       Date:  2017-02-10       Impact factor: 19.318

2.  Asn441 plays a key role in folding and function of the Na+/I- symporter (NIS).

Authors:  Wenjing Li; Juan Pablo Nicola; L Mario Amzel; Nancy Carrasco
Journal:  FASEB J       Date:  2013-05-06       Impact factor: 5.191

Review 3.  Defects of Thyroid Hormone Synthesis and Action.

Authors:  Zeina C Hannoush; Roy E Weiss
Journal:  Endocrinol Metab Clin North Am       Date:  2017-03-06       Impact factor: 4.741

4.  Na+ coordination at the Na2 site of the Na+/I- symporter.

Authors:  Giuseppe Ferrandino; Juan Pablo Nicola; Yuly E Sánchez; Ignacia Echeverria; Yunlong Liu; L Mario Amzel; Nancy Carrasco
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-25       Impact factor: 11.205

Review 5.  The Na+/I- symporter (NIS): mechanism and medical impact.

Authors:  Carla Portulano; Monika Paroder-Belenitsky; Nancy Carrasco
Journal:  Endocr Rev       Date:  2013-12-04       Impact factor: 19.871

6.  Mapping of Ion and Substrate Binding Sites in Human Sodium Iodide Symporter (hNIS).

Authors:  Hristina R Zhekova; Toshie Sakuma; Ryan Johnson; Susanna C Concilio; Patrycja J Lech; Igor Zdravkovic; Mirna Damergi; Lukkana Suksanpaisan; Kah-Whye Peng; Stephen J Russell; Sergei Noskov
Journal:  J Chem Inf Model       Date:  2020-03-12       Impact factor: 4.956

7.  Sodium/Iodide Symporter Mutant V270E Causes Stunted Growth but No Cognitive Deficiency.

Authors:  Juan Pablo Nicola; Andrea Reyna-Neyra; Paul Saenger; David F Rodriguez-Buritica; José David Gamez Godoy; Radhika Muzumdar; L Mario Amzel; Nancy Carrasco
Journal:  J Clin Endocrinol Metab       Date:  2015-07-23       Impact factor: 5.958

8.  A Novel SLC5A5 Variant Reveals the Crucial Role of Kinesin Light Chain 2 in Thyroid Hormonogenesis.

Authors:  Mariano Martín; Carlos Pablo Modenutti; Mauco Lucas Gil Rosas; Victoria Peyret; Romina Celeste Geysels; Carlos Eduardo Bernal Barquero; Gabriela Sobrero; Liliana Muñoz; Malvina Signorino; Graciela Testa; Mirta Beatriz Miras; Ana María Masini-Repiso; Nora Beatriz Calcaterra; Gabriela Coux; Nancy Carrasco; Marcelo Adrián Martí; Juan Pablo Nicola
Journal:  J Clin Endocrinol Metab       Date:  2021-06-16       Impact factor: 5.958

9.  The Iodide Transport Defect-Causing Y348D Mutation in the Na+/I- Symporter Renders the Protein Intrinsically Inactive and Impairs Its Targeting to the Plasma Membrane.

Authors:  Andrea Reyna-Neyra; Lara Jung; Mayukh Chakrabarti; Mikel X Suárez; L Mario Amzel; Nancy Carrasco
Journal:  Thyroid       Date:  2021-06-04       Impact factor: 6.506

10.  Beyond non-integer Hill coefficients: A novel approach to analyzing binding data, applied to Na+-driven transporters.

Authors:  Silvia Ravera; Matthias Quick; Juan P Nicola; Nancy Carrasco; L Mario Amzel
Journal:  J Gen Physiol       Date:  2015-06       Impact factor: 4.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.